DUOBODY Trademark
DUOBODY is a USPTO trademark filed by Genmab A/S. Status: Registered.
Prosecution Summary
Trademark Summary
DUOBODY is a word service mark covering biochemicals, namely monoclonal antibodies for in vivo or in vitro scientific research and development regarding cancer, AIDS (acquired immune deficiency syndrome), other infectious diseases, immune and autoimmune diseases, inflammatory diseases, and cardiovascular diseases; pharmaceutical preparations based on human monoclonal antibodies for the treatment of those conditions; medical and scientific research (including biological scientific research into human monoclonal antibodies and development of pharmaceutical products based on human monoclonal antibodies), chemical analysis, and computer programming for collection and processing of medical data in medical scientific research, development, and therapy with monoclonal
Trademark Facts
| Mark | DUOBODY |
|---|---|
| Serial Number | 79093886 |
| Registration Number | 4103714 |
| Status | Registered |
| Filing Date | 2010-12-30 |
| Registration Date | 2012-02-28 |
| Mark Type | Word |
| Nice Classes | 001 (Chemicals) |
| Owner | Genmab A/S |
| Attorney of Record | Max Vern |
| Prosecution Events | 49 |
| Latest Event | CHAN on 2024-06-05 |
Goods & Services
Biochemicals, namely, monoclonal antibodies for in vivo or in vitro scientific research and development regarding cancer, AIDS (acquired immune deficiency syndrome), and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases | Pharmaceutical preparations based on human monoclonal antibodies for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases | Medical and scientific research, namely, biological scientific research into human monoclonal antibodies and development of pharmaceutical products based on human monoclonal antibodies for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases; chemical analysis; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy with monoclonal antibodies | Patent exploitation, namely, patent licensing ; licensing of intellectual property in the field of medicine